Premium
Double‐blind, placebo‐controlled study of magnesium hydroxide for treatment of sensory urgency and detrusor inst ability: preliminary results
Author(s) -
Gordon David,
Groutz Asnat,
AscherLandsberg Jessica,
Lessing Joseph B.,
David Menachem P,
Razz Olga
Publication year - 1998
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.1998.tb10183.x
Subject(s) - placebo , cystometry , magnesium , medicine , detrusor instability , anesthesia , placebo group , urinary system , chemistry , alternative medicine , organic chemistry , pathology
In a prospective, randomised, double‐blind, placebo‐controlled study 40 women with sensory urgency or detrusor instability randomly received either magnesium hydroxide (group A) or placebo (group B). Pre‐ and post‐treatment symptoms, frequency‐volume charts and cystometry results were compared. Eleven of 20 patients receiving magnesium (55%) reported a subjective improvement of their urinary symptoms, compared with five patients taking placebo (20%) In both study groups there was no statistically significant difference in pre‐ and posttreatment urodynamic parameters in those reporting symptomatic improvement. Magnesium was well tolerated by patients in group A, and no side effects were reported. These results suggest that magnesium hydroxide may be beneficial for detrusor instability or sensory urgency in women.